Relation Therapeutics Ltd, a virtual drug discovery company, has raised $35m in seed financing, bringing its total seed fundraise to $60m. The financing round was led by DCVC and co-led by NVIDIA’s venture arm, with participation from existing and new investors. The funds will be used to accelerate the discovery of novel biology, targets, and medicines. Relation Therapeutics focuses on generative AI drug discovery. Their platform generates and analyzes human data to understand disease biology, discover novel targets, and develop medicines. Their current focus is on osteoporosis.
📢 Virtual Drug Discovery Startup Raises $35m to Revolutionize Medicine
Introduction:
London-based virtual drug discovery specialist, Relation Therapeutics Ltd, has raised $35 million in seed financing, bringing its total seed fundraise to $60 million.
Main points:
- The funding round was led by DCVC and co-led by NVIDIA’s venture arm, NVentures, with participation from initial seed lead Magnetic Ventures, existing investors Khosla Ventures, and Abcam founder Jonathan Milner, as well as new investors ARK Invest and Deerfield Management Company.
- Relation Therapeutics uses generative AI to discover novel biology, targets, and medicines. Their platform integrates single-cell analysis, genomics, and machine learning to build maps of disease biology and develop novel therapies.
- The funds raised will be used to advance their pipeline for osteoporosis treatment and support the discovery of new therapies in other therapeutic areas.
- Relation Therapeutics has built proprietary data resources, including Osteomics, a clinical observational study, to create the world’s largest functional, single-cell bone atlas derived from human patient tissue.
- The company’s Lab-in-the-Loop approach combines single-cell multi-omics directly from patient tissue, functional assays, and machine learning to understand biological processes and develop targeted treatments.
Conclusion:
Relation Therapeutics has secured $35 million in seed financing to advance their drug discovery efforts using generative AI. The funding will support their research and development of novel therapies, starting with treatments for osteoporosis. By combining advanced technologies such as single-cell analysis, genomics, and machine learning, Relation Therapeutics aims to accelerate the discovery and development of targeted medicines for various diseases.
